Maharashtra FDA staff flag long shifts and vacancies, raising testing-quality concerns

Twenty-nine Maharashtra FDA laboratory employees and officers have complained about two-shift schedules, 9 a.m.-to-midnight workdays and staffing vacancies. They warn that rushed testing of food, drug and cosmetic samples could affect quality and slow regulatory clearances.

— Source publishedThu, 30 Jul, 2026, 11:12 IST·First seen Thu, 30 Jul, 2026, 12:38 IST·Source NDTV Profit

What happened

Maharashtra Food and Drug Administration · Maharashtra FDA laboratory staff complained about two-shift schedules, extended workdays and vacancies, warning that

Key facts

  • 29 employees and officers
  • 15 July
  • 9 a.m. to midnight

Why this matters

Factor potential approval backlogs and compliance uncertainty into diligence, valuation assumptions and integration plans for regulated assets in Maharashtra.

What to watch

  • Formal Maharashtra FDA response to the employees' complaint, including shift-policy changes or recruitment announcements.
  • Reported number of unfilled laboratory posts, resignations, sick leave and overtime hours.
  • Turnaround times for food, pharmaceutical and cosmetic sample reports versus statutory or internal targets.
  • Any recall, court challenge, contested prosecution or retesting linked to laboratory delay or alleged testing error.
  • State budget allocations for FDA laboratories, equipment modernization, outsourced testing or contractual staff.
  • Escalation by employee associations, including work-to-rule action, strike threats or litigation.
  • Maharashtra FDA management is likely to seek temporary staffing, revised shift rosters and approval to fill vacant laboratory posts.
  • Laboratory leadership may triage samples by public-health risk, prioritizing suspected adulteration, drug-quality failures and outbreak-related food testing over routine clearances.
  • Industry groups may increase use of accredited private laboratories where permitted and lobby for defined turnaround-time commitments.
  • The state health and food-and-drug departments may face pressure to publish vacancy counts, pending-sample backlogs and laboratory turnaround metrics.